Haemonetics Corporation (HAE)

Fixed asset turnover

		Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	US$ in thousands	1,360,820	1,309,060	1,168,660	993,196	870,463
Property, plant and equipment	US$ in thousands	—	—	310,885	258,482	277,415
Fixed asset turnover		—	—	3.76	3.84	3.14

March 31, 2025 calculation

Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $1,360,820K ÷ $—K
= —

The fixed asset turnover ratio for Haemonetics Corporation has shown a positive trend over the past few years, steadily increasing from 3.14 in March 31, 2021, to 3.84 in March 31, 2022, and then slightly decreasing to 3.76 in March 31, 2023. However, there is missing data for the years March 31, 2024 and 2025, which makes it difficult to assess the most recent performance.

This ratio indicates that for every dollar invested in fixed assets, Haemonetics is generating a relatively high amount of revenue. A higher fixed asset turnover ratio generally suggests that the company is effectively utilizing its fixed assets to generate sales.

Overall, the trend in the fixed asset turnover ratio indicates that Haemonetics has been efficient in managing its fixed assets to generate revenue, but additional data would be needed to fully assess its ongoing performance in this aspect.